Ilyang Pharmaceutical Co Ltd (007575) — Free Cash Flow Generation Index
Ilyang Pharmaceutical Co Ltd (007575) has a Free Cash Flow Generation Index of -0.47x as of June 2025. Free cash flow of ₩-1.06 Billion represents 0% of operating cash flow (₩2.26 Billion). Read debt load of Ilyang Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ilyang Pharmaceutical Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Ilyang Pharmaceutical Co Ltd across 11 annual periods. Explore Ilyang Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Ilyang Pharmaceutical Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Ilyang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Ilyang Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.23x | ₩-35.01 Billion | ₩5.61 Billion | ₩40.62 Billion | ▼ -1270.6% |
| 2023 | 0.53x | ₩7.79 Billion | ₩14.62 Billion | ₩6.83 Billion | ▲ +69.6% |
| 2022 | 0.31x | ₩9.40 Billion | ₩29.94 Billion | ₩4.08 Billion | ▼ -53.9% |
| 2021 | 0.68x | ₩45.67 Billion | ₩67.02 Billion | ₩12.91 Billion | ▲ +19.2% |
| 2020 | 0.57x | ₩32.86 Billion | ₩57.48 Billion | ₩10.17 Billion | ▼ -25.6% |
| 2019 | 0.77x | ₩27.81 Billion | ₩36.19 Billion | ₩2.17 Billion | ▲ +36.6% |
| 2018 | 0.56x | ₩12.44 Billion | ₩22.12 Billion | ₩1.55 Billion | ▼ -19.2% |
| 2017 | 0.70x | ₩20.91 Billion | ₩30.03 Billion | ₩3.78 Billion | ▼ -49.6% |
| 2016 | 1.38x | ₩37.29 Billion | ₩26.98 Billion | ₩10.31 Billion | ▼ -1.2% |
| 2015 | 1.40x | ₩56.35 Billion | ₩40.27 Billion | ₩16.07 Billion | ▼ -19.8% |
| 2014 | 1.75x | ₩32.51 Billion | ₩18.63 Billion | ₩13.89 Billion | — |